Mode
Text Size
Log in / Sign up
N/A N=269 Randomized Single-blind Prevention

Intervention Trial to Decrease Cardiovascular Risk in Persons With Serious Mental Illness

Cardiovascular Risk Factors · Serious Mental Illness

Enrolled (actual)
269
Serious AEs
23.8%
Results posted
Aug 2025
Primary outcome: Primary: Global Framingham Risk Score — 11.5; 12.7; 9.9; 12.3 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
IDEAL intervention (Other); Control (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Johns Hopkins University
Primary completion
Nov 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Global Framingham Risk Score
11.5; 12.7; 9.9; 12.3
SECONDARY
Weight in Pounds
219.5; 208.6; 216.9; 208.3; 213.2; 202.9
SECONDARY
Body Mass Index (BMI)
34.4; 32.9; 33.7; 32.1
SECONDARY
Distance Traveled in the 6 Minute Walk Test
909.5; 910.7; 922.9; 926.9; 925.1; 910.7
SECONDARY
Healthy Diet as Indicated by Sugar Sweetened Beverage Consumption
8.8; 9.8; 8.4; 11.1; 9.1; 11.3
SECONDARY
Healthy Diet as Indicated by Fast Food Consumption
4.3; 3.9; 3.7; 5.2; 3.8; 3.8
SECONDARY
Fasting Glucose Level
106.5; 110.6; 106.7; 117.4
SECONDARY
Participants With Diabetes Mellitus Treated to Goal (HgBA1c)
27; 25; 15; 26; 29; 23
SECONDARY
Current Smoking Status
65; 73; 47; 67
SECONDARY
Blood Pressure
118.0; 116.5; 75.3; 74.9; 120.1; 120.2
SECONDARY
Participants With Hypertension Treated to Goal
61; 54; 11; 16; 62; 55
SECONDARY
Total Cholesterol
178.9; 181.1; 171.8; 177.7
SECONDARY
LDL Cholesterol
101.9; 101.0; 93.7; 97.3
SECONDARY
HDL Cholesterol
49.2; 50.2; 50.7; 51.0
SECONDARY
Triglycerides
140.2; 156.6; 141.0; 149.0
SECONDARY
Participants With Dyslipidemia Treated to Goal
46; 53; 36; 40; 47; 55

Summary

This study will determine whether a program where a health coach works with participants on heart healthy behaviors and treatment of risk factors is coordinated with primary care can reduce overall heart disease risk in people with serious mental illness.

Eligibility Criteria

Inclusion Criteria

  • ▪ Age 18 and older

▪ Body mass index at least 25 kg/m2 OR one of the following CVD risk factors:

  • Hypertension (SBP>= 140mmHg or DBP>= 90mmHg or on antihypertensive medications;
  • Diabetes mellitus (fasting blood sugar> 125mg/dl or hemoglobin A1c>6.5 or on a hypoglycemic medication);
  • Dyslipidemia (LDL >130 mg/dl , HDL =200 or on a lipid lowering agent);
  • Current tobacco smoker
  • Able and willing to give informed consent
  • Completion of baseline data collection
  • Willing to accept randomization
  • Willing to participate in the intervention

Exclusion Criteria

  • ▪ Cardiovascular event (unstable angina, myocardial infarction) within the past 6 months
  • Serious medical condition which either limits life expectancy or requires active management (e.g., certain cancers)
  • Condition which interferes with outcome measurement (e.g., dialysis)
  • Pregnant or planning a pregnancy during study period. Nursing mothers would need approval from physician.
  • Alcohol or substance use disorder if not sober/abstinent for 30 days
  • Planning to leave rehabilitation center or clinic within 6 months or move out of geographic area within 18 months
  • Investigator judgment (e.g., for concerns about participant or staff safety)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02127671). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search